<p>β-lactamase
mediated antibiotic resistance threatens treatment of bacterial infections.
OXA-48 enzymes are clinically important class D serine β-lactamases (SBLs) that
confer resistance to most β-lactam antibiotics, including carbapenems. However,
OXA-48 and related enzymes vary widely in their activity towards different
substrates: OXA-48 primarily hydrolyzes carbapenems, whereas the OXA-163
variant is a cephalosporinase with minimal carbapenemase activity. The basis of
cephalosporinase activity in OXA-163 remains elusive. Here we use QM/MM
reaction simulations (umbrella sampling molecular dynamics) to study breakdown
of the cephalosporin antibiotic ceftazidime, a key antibiotic for
healthcare-associated infections, by selected OXA-48 variants. Calculated free energy
barriers for ceftazidime deacylation correctly capture the differing catalytic
efficiencies of the studied enzymes and identify the catalytically competent
orientation for bound ceftazidime. Additionally, we show that high flexibility
of the Ω-loop bordering the active site, a determinant of specificity in many
SBLs, is not required for efficient deacylation. Based on our simulations,
cephalosporin breakdown in OXA-163 is efficient due to subtle control of active
site solvation, which requires a particular orientation of Leu158 in the
Ω-loop. Our simulations further predict that a single mutation in the OXA-48 β5
- β6 loop (Arg214Ser) will increase the efficiency of ceftazidime deacylation
to that of OXA-163. The finding that the hydration of the general base in the
active site determines deacylation efficiency is possibly important in other
class D β-lactamases.<br></p>